Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,125 | 6,071 | 21,092 | 27,446 | 14,568 |
| Marketable Securities | N/A | 17,859 | 39,712 | 53,898 | N/A |
| Receivables | 48 | 38 | 302 | N/A | N/A |
| TOTAL | $24,787 | $25,596 | $62,444 | $83,266 | $21,472 |
| Non-Current Assets | |||||
| PPE Net | 23 | 51 | 69 | 91 | 421 |
| Intangibles | 19,746 | 0 | 1,719 | 3,435 | 0 |
| Other Non-Current Assets | 39 | 612 | 2,601 | 4,717 | 10,899 |
| TOTAL | $19,808 | $663 | $4,389 | $8,243 | $11,320 |
| Total Assets | $44,595 | $26,259 | $66,833 | $91,509 | $32,792 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,627 | 6,374 |
| Accounts payable and accrued liabilities | 251 | 4,996 | 2,774 | 878 | 816 |
| Accrued Expenses | 2,651 | 7,761 | 4,346 | 1,165 | 1,829 |
| Other current liabilities | 14,703 | 761 | 1,944 | 9,050 | 32,577 |
| TOTAL | $17,605 | $13,518 | $9,064 | $12,941 | $41,698 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,300 | 11,453 | 10,094 | 6,930 | 22,462 |
| Other Non-Current Liabilities | 10,771 | 7,691 | 19,676 | 21,404 | 19,191 |
| TOTAL | $31,071 | $19,144 | $29,770 | $28,334 | $41,653 |
| Total Liabilities | $48,676 | $32,662 | $38,834 | $41,275 | $83,351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,581 | 16,427 | 12,706 | 12,191 | 11,771 |
| Common Shares | 315 | 135 | 126 | 122 | 494 |
| Retained earnings | -486,072 | -461,298 | -422,927 | -378,493 | -286,929 |
| Other shareholders' equity | 0 | 1 | -350 | 0 | 0 |
| TOTAL | $-4,081 | $-6,403 | $27,999 | $50,234 | $-50,559 |
| Total Liabilities And Equity | $44,595 | $26,259 | $66,833 | $91,509 | $32,792 |